211 related articles for article (PubMed ID: 16761932)
1. Nonplatinum therapy in advanced bladder cancer.
Srinivas S; Colocci N
Expert Rev Anticancer Ther; 2006 Jun; 6(6):887-94. PubMed ID: 16761932
[TBL] [Abstract][Full Text] [Related]
2. Update on chemotherapy for advanced bladder cancer.
Rosenberg JE; Carroll PR; Small EJ
J Urol; 2005 Jul; 174(1):14-20. PubMed ID: 15947569
[TBL] [Abstract][Full Text] [Related]
3. Perioperative chemotherapy for bladder cancer.
Sonpavde G; Petrylak DP
Crit Rev Oncol Hematol; 2006 Feb; 57(2):133-44. PubMed ID: 15990329
[TBL] [Abstract][Full Text] [Related]
4. Systemic chemotherapy options for metastatic bladder cancer.
Siefker-Radtke A
Expert Rev Anticancer Ther; 2006 Jun; 6(6):877-85. PubMed ID: 16761931
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer.
Calabrò F; Sternberg CN
Eur Urol; 2009 Feb; 55(2):348-58. PubMed ID: 18977070
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy in invasive bladder cancer.
Bamias A; Dimopoulos MA
Expert Rev Anticancer Ther; 2005 Dec; 5(6):993-1000. PubMed ID: 16336090
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy for advanced bladder cancer.
Roth BJ
Semin Oncol; 1996 Oct; 23(5):633-44. PubMed ID: 8893874
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
Muramaki M; Miyake H; Kurahashi T; Takenaka A; Inoue TA; Fujisawa M
Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy practices and perspectives in invasive bladder cancer.
Flechon A; Droz JP
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1473-82. PubMed ID: 17069531
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of bladder carcinoma. Current status and trends].
Block T
Urologe A; 1994 Nov; 33(6):557-67. PubMed ID: 7817457
[TBL] [Abstract][Full Text] [Related]
11. Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.
Pectasides D; Pectasides M; Economopoulos T
Cancer Treat Rev; 2006 Oct; 32(6):456-70. PubMed ID: 16935429
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors of the epidermal growth factor receptor as adjuncts to systemic chemotherapy for muscle-invasive bladder cancer.
McHugh LA; Griffiths TR; Kriajevska M; Symonds RP; Mellon JK
Urology; 2004 Apr; 63(4):619-24. PubMed ID: 15072863
[No Abstract] [Full Text] [Related]
13. Advanced bladder cancer: status of first-line chemotherapy and the search for active agents in the second-line setting.
Gallagher DJ; Milowsky MI; Bajorin DF
Cancer; 2008 Sep; 113(6):1284-93. PubMed ID: 18629841
[TBL] [Abstract][Full Text] [Related]
14. Systemic therapy of metastatic bladder cancer in the molecular era: current status and future promise.
Zachos I; Konstantinopoulos PA; Tzortzis V; Gravas S; Karatzas A; Karamouzis MV; Melekos M; Papavassiliou AG
Expert Opin Investig Drugs; 2010 Jul; 19(7):875-87. PubMed ID: 20528482
[TBL] [Abstract][Full Text] [Related]
15. Emerging apoptosis agonists for bladder cancer.
Protzel C; Hakenberg OW
Expert Opin Emerg Drugs; 2009 Dec; 14(4):607-18. PubMed ID: 19772372
[TBL] [Abstract][Full Text] [Related]
16. First- and second-line therapy of metastatic colorectal cancer.
Terstriep S; Grothey A
Expert Rev Anticancer Ther; 2006 Jun; 6(6):921-30. PubMed ID: 16761936
[TBL] [Abstract][Full Text] [Related]
17. Perioperative chemotherapy in muscle-invasive bladder cancer to enhance survival and/or as a strategy for bladder preservation.
Sternberg CN
Semin Oncol; 2007 Apr; 34(2):122-8. PubMed ID: 17382795
[TBL] [Abstract][Full Text] [Related]
18. [Neoadjuvant chemotherapy in muscle-invasive bladder cancer].
Miyanaga N; Akaza H
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1745-9. PubMed ID: 18030008
[TBL] [Abstract][Full Text] [Related]
19. Metastatic colorectal cancer.
Saletti P; Cavalli F
Cancer Treat Rev; 2006 Nov; 32(7):557-71. PubMed ID: 16935430
[TBL] [Abstract][Full Text] [Related]
20. Adverse events of MVAC chemotherapy in patients with advanced urothelial cancer of the bladder.
Maeda T; Takahashi A; Hirobe M; Honma I; Masumori N; Itoh N; Tsukamoto T
Hinyokika Kiyo; 2007 Apr; 53(4):213-9. PubMed ID: 17515069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
